LINC02126

Across TCGA pan-cancer cohorts, LINC02126 RNA is linked to patient survival in 24 of 34 cancer types, making it the most broadly survival-associated LINC02126 data layer.

The strongest signal is observed in adrenocortical carcinoma (ACC), where higher LINC02126 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated LINC02126 expression acts as an unfavorable survival marker, although some lineages such as LUAD and BRCA show a favorable association.

ACC, UVM, and KICH are the cancer types where LINC02126 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ACC	OS	Median	All	0.762	0.927	<.001	91	view →
UVM	DFS	Tertile	All	0.306	0.768	.012	72	view →
KICH	DFS	Tertile	All	0.484	0.909	<.001	63	view →
BLCA	OS	Quartile	All	0.285	0.597	.002	62	view →
KIRC	OS	Tertile	All	0.549	0.707	<.001	59	view →
STAD	OS	Tertile	All	0.454	0.755	<.001	52	view →
KIRP	OS	Tertile	All	0.458	0.750	<.001	45	view →
LUAD	DFS	Median	All	0.831	0.748	.005	24	view →
TGCT	DFS	Quartile	All	0.733	0.950	.005	18	view →
LUSC	OS	Quartile	II,III,IV	0.480	0.675	.014	15	view →
BRCA	DFS	Quartile	IV	0.934	0.274	.025	12	view →
THYM	DFS	Median	All	0.965	0.657	.003	11	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 24 lineages.

LINC02126–ACC (OS)

Open the ACC breakdown →